GWPH - GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q2 2019 Results - Earnings Call Transcript
GW Pharmaceuticals plc (GWPH)
Q2 2019 Earnings Conference Call
August 6, 2019 4:30 PM ET
Company Participants
Stephen Schultz – Vice President-Investor Relations
Justin Gover – Chief Executive Officer
Darren Cline – U.S. Chief Commercial Officer
Chris Tovey – Chief Operating Officer
Volker Knappertz – Chief Medical Officer
Scott Giacobello – Chief Financial Officer
Conference Call Participants
Tazeen Ahmad – Bank of America
Cory Kasimov – JPMorgan
David Lebowitz – Morgan Stanley
Paul Matteis – Stifel
Phil Nadeau – Cowen and Company
Marc Goodman – SVB Leerink
Esther Rajavelu – Oppenheimer and Company
Yatin Suneja